Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

NOS3 rs1800779 and endothelial dysfunction: Gene diet interactions in cardio metabolic health and personalised nutrition

Breadcrumb

  • Home
  • NOS3 rs1800779 and endothelial dysfunction: Gene diet interactions in cardio metabolic health and personalised nutrition

Dr Shamya Reny *

 MRC Epidemiology Unit, University of Cambridge, School of Medicine, Cambridge, UK.

Review Article

World Journal of Biology Pharmacy and Health Sciences, 2025, 23(01), 085–089

Article DOI: 10.30574/wjbphs.2025.23.1.0657

DOI url: https://doi.org/10.30574/wjbphs.2025.23.1.0657

Received on 27 May 2025; revised on 05 July 2025; accepted on 07 July 2025

The endothelial nitric oxide synthase gene (NOS3) plays a central role in vascular health by regulating nitric oxide (NO) synthesis, a molecule vital for endothelial function and cardiovascular integrity. Among its polymorphisms, rs1800779 (−922A>G), located in the promoter region, has been linked to altered gene expression and reduced NO bioavailability. This review explores the influence of the rs1800779 variant on endothelial function and its associations with cardiovascular, metabolic, and respiratory disorders. Emerging evidence suggests that carriers of the G allele (AG or GG genotypes) exhibit diminished NOS3 expression and increased susceptibility to endothelial dysfunction, hypertension, insulin resistance, and impaired lung function. The review further examines gene diet interactions involving this polymorphism, highlighting how specific dietary components such as nitrates, omega-3 fatty acids, antioxidants, and nutraceuticals may mitigate the negative effects associated with reduced NO synthesis. Personalised dietary strategies based on genotype may offer promising avenues to restore vascular health and reduce chronic disease risk. Integrating nutrigenomic insights into clinical and public health practices holds potential for developing targeted nutritional interventions that support endothelial function and improve long-term health outcomes.

NOS3; Rs1800779 Polymorphism; Endothelial Dysfunction; Nitric Oxide; Gene Diet Interaction; Personalised Nutrition

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2025-0657.pdf

Preview Article PDF

Dr Shamya Reny. NOS3 rs1800779 and endothelial dysfunction: Gene diet interactions in cardio metabolic health and personalised nutrition. World Journal of Biology Pharmacy and Health Sciences, 2025, 23(01), 085-089. Article DOI: https://doi.org/10.30574/wjbphs.2025.23.1.0657. 

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution